The new inotropic drug, dobutamine
Huss, P.; Miller, J.; Unverferth, D.V.; Leier, C.V.
Heart and Lung the Journal of Critical Care 10(1): 121-126
1981
ISSN/ISBN: 0147-9563 PMID: 6905822 Document Number: 181571
Document emailed within 1 workday
Related Documents
Cleary, J.D. 1988: Two inotropic agents: dopamine and dobutamine Pediatric Nursing 14(5): 414Ismail-Zade, I.A.; Trifonova, N.A.; Stepanenko, S.M. 1994: Use of the current cardiac inotropic agent dobutamine in pediatric surgical clinics Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 3: 31-34
Ishihata, A.; Kushida, H.; Endoh, M. 1988: Enantiomers of dobutamine increase the force of contraction via beta adrenoceptors, but antagonize competitively the positive inotropic effect mediated by alpha-1 adrenoceptors in the rabbit ventricular myocardium Journal of Pharmacology and Experimental Therapeutics 246(3): 1080-1087
Mutnick, A.H.; Souney, P.F. 1988: Dobutamine: a drug utilization evaluation Hospital Formulary 23(5): 461
Lanzarini, L.; Previtali, M.; Ferrario, M.; Mussini, A.; Poli, A.; Fetiveau, R.; Montemartini, C. 1992: Comparison of results of echo-dobutamine and ECG-dobutamine tests in the diagnosis of coronary disease Giornale Italiano di Cardiologia 22(8): 953-961
Dahlin, P.A.; Paredes, S.M. 1980: Visual compatibility of dobutamine with seven parenteral drug products American Journal of Hospital Pharmacy 37(4): 460; 464
Diederen, W.; Weisenberger, H. 1981: Studies on the mechanism of the positive-inotropic action of AR-L 115 BS, a new cardiotonic drug Arzneimittel-Forschung 31(1a): 177-182
Earl, C.Q.; Linden, J.; Weglicki, W.B. 1986: Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone Journal of Cardiovascular Pharmacology 8(4): 864-872
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Jaafari, A.ïc.; Boukhriss, B.; Mkadem, A.ïd.; Benyoussef, S. 2003: Indications for dobutamine stress echocardiography La Tunisie Medicale 81(12): 914-918
Yang, J.S. 1997: Care of patients under dobutamine stress echocardiography Zhonghua Hu Li Za Zhi 32(4): 207-208
Oh, T.; Franko, T.G.; Rumsey, K. 1989: Standardized concentrations for dobutamine hydrochloride admixtures American Journal of Hospital Pharmacy 46(2): 262
Trojnar, R.; Kutarski, A.; Kedra, W.A.; Rymar, B.; Markiewicz, M. 1983: Use of dobutamine in the treatment of post-infarction shock Wiadomosci Lekarskie 36(7): 531-536
Nieminen, M.S. 2003: Levosimendan compared with dobutamine in low output patients Minerva Anestesiologica 69(4): 258-263
Nixdorff, U. 2002: Dobutamine was approved for stress echocardiography indications Herz 27(8): 822
Strosberg, A.M.; Montgomery, W. 1981: Cardioselectivity of dobutamine and prenalterol in the pentobarbital anesthetized dog Proceedings of the Western Pharmacology Society 24: 83-87
Roudaut, R. 1997: Dobutamine stress echocardiography; a tool in maturity Archives des Maladies du Coeur et des Vaisseaux 90(11): 1453
Witchitz, S.; Fournier, C.; Extramiana, F.; Mokaddem, J.; Arsenescu, I. 1999: Diagnostic value of electrocardiography using dobutamine in coronary artery disease Presse Medicale 28(36): 1971-1974
Goethals, M.; Demey, H. 1984: Massive dobutamine overdose in a cardiovascular compromised patient Acta Cardiologica 39(5): 373-378
Heinen, E.; Herrmann, J.; Lippe, J.; Dudek, M.; Krüskemper, H.L. 1983: Effect of dopamine and dobutamine on thyroid hormone concentration Die Medizinische Welt 34(24): 696-699